Garenoxacin mesylate hydrate
CAS: 223652-90-2
Ref. 3D-FG40128
1mg | To inquire | ||
2mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Product Information
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrate (1:1:1)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, methanesulfonate, hydrate (1:1:1)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, monomethanesulfonate, monohydrate
- Geninax
Garenoxacin mesylate hydrate is a quinolone antibiotic that suppresses the growth of bacteria by inhibiting DNA-dependent RNA polymerase in prokaryotes. It has been shown to be active against a wide range of bacterial strains. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death.
Chemical properties
Technical inquiry about: 3D-FG40128 Garenoxacin mesylate hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.